Select Committee · Science and Technology Committee (Commons)
Commercialising Research
Status: Closed
Opened: 15 May 2024
Closed: 28 May 2024
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Date | Session and witnesses | Source |
|---|---|---|
| 22 May 2024 |
Commercialising Research
Byron Dixon OBE · Micro-Fresh,
Dr David Wilkes · Innovate UK (UK Research and Innovation),
Julian Hanak · Purespring Therapeutics,
Rosa Wilkinson · High Value Manufacturing Catapult,
Simon Andrews · Fraunhofer UK
|
View ↗ |
Who gave evidence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Witness | Organisation | Sessions |
|---|---|---|
| Byron Dixon OBE · CEO | Micro-Fresh | 1 |
| Dr David Wilkes · Director of Innovation Ecosystem | Innovate UK (UK Research and Innovation) | 1 |
| Julian Hanak · CEO | Purespring Therapeutics | 1 |
| Rosa Wilkinson · Director of Policy | High Value Manufacturing Catapult | 1 |
| Simon Andrews · Executive Director | Fraunhofer UK | 1 |